Message Containing Symbol KWBT (Kiwa Bio-tech Products Group Corp.)

OUR LAST PICK

*************************************************************************

Congratulations to all investors who took advantage of our last Stock Pick!!!



GRYW - The stock was initially profiled at .40 cents and reached $1.80 in two
weeks.



The situation with our new stock pick is similar so jump on it now to get in on
the move!

*************************************************************************



++ Major Trading Alert : Late breaking news...++



******Investors have not yet had the opportunity to trade on this
information.******



After the close of trading on Friday, Kiwa biotech announced...



Three Orders in Q2 Represent an aggregate 700% Increase from Distributors=20
Previous Orders in Dollar Terms



LOS ANGELES, June 25, 2004 (PRIMEZONE) -- Kiwa Bio-Tech Products Group
Corporation (``the Company'' or ``KIWA'') (OTC BB:KWBT)

announced today that a China-based distributor of its products has placed its
third order this quarter, which represents a significant

increase over the previous order by this repeat customer. Entering Q2, the
distributor placed three orders which total 7 times the size

of the order placed by this customer in Q1.



******Investors have not yet had the opportunity to trade on this
information.******



The hottest stock Today - Watch KWBT



We expect some strong demand for this stock in the near future!!!!!



The Stock is EXTREMELY TIGHT - The float is only 4M shares!!!



Get on Board now and enjoy some great profits with KWBT



CURRENT PRICE - $.32



SPECULATIVE NEAR TERM TARGET PRICE - $.80

SPECULATIVE LONG TERM TARGET PRICE - $1.85



KWBT* KWBT* KWBT* KWBT* KWBT* KWBT* KWBT* KWBT* KWBT* KWBT * KWBT



About the Company:

------------------------------------------------------------------------

Based in the City of Industry, California, with manufacturing centers in
mainland China, KIWA Bio-Tech Products Group Corporation is a public company (OTCBB:
KWBT)

that develops, manufactures and distributes innovative, cost-effective, and
environmentally-safe biotechnology products to agricultural markets. The company
is a pioneer in commercialization of biotechnology, having a manufacturing base
in Shandong Province, China and plans to distribute bio-tech products worldwide.



With 20 years of research and development experience in biotechnology, KIWA's
patented products are produced through a cost-effective manufacturing process. 
KIWA's first marketplace entry is Mainland China, with an American presence
planned by 2005. With approval and subsidies from the Chinese government, KIWA
has established a manufacturing center which is a well developed distribution
point for the world's most populated country.



The Market:

-------------------------------------------------------------------------

KIWA Bio-Tech recognized early the dire need in mainland China for affordable,
easy-to-use organic agricultural products, as well as the difficulties in

distributing their products to farmers in the world's most populous country.
With over 1.3 billion people, China possesses 7% of the world's agricultural
land but supports 20% of the world's population. With these demands the strain
on arable land in China is enormous. Overuse of chemical herbicides and
insecticides hold the potential to destroy the limited water supply of China,
making organic compounds an obvious alternative.



With China's underdeveloped farm communities, KIWA strives to provide the=20
average local farmer with the ability to grow higher quality produce and greater
crop yields.  Agribusiness is 14% of China's Gross Domestic Product,=20
totaling as much as $180 billion in 2002 alone. With this type of market
potential, China was an obvious first choice for KIWA's full-scale entry into
the "Agri-Bio" marketplace. In the coming year an entrance into the American
agricultural market is planned, but KIWA will establish the immense value of
their product in Chinese agribusiness first.



-------------------------------------------------------

We wish you profitable trading!!



---------------

Disclaimer

---------------

Information within this email contains "forward looking
statements" within the meaning of Section 27A of the Securities Act of 1933 and
Section 21B of the Securities Exchange Act of 1934.   Any statements
that express or involve discussions with respect to predictions, goals,
expectations, beliefs, plans, projections, objectives, assumptions or future
events or performance are not statements of historical fact and may be "forward
looking statements."



Forward looking statements are based on expectations, estimates and projections
at the time the statements are made that involve a number of risks and
uncertainties which could cause

actual results or events to differ materially from those presently anticipated.
Forward looking statements in this action may be identified through the use of
words such as:

"projects", "foresee", "expects", "estimates," "believes," "understands" "will,"
"part of: "anticipates," or that by statements indicating certain actions "may,"
"could," or "might" occur.

All information provided within this email pertaining to investing, stocks,
securities must be understood as information provided and not investment advice.
Emerging Equity Alert advises

all readers and subscribers to seek advice from a registered professional=20
securities representative before deciding to trade in stocks featured within
this email. None of the material within

this report shall be construed as any kind of investment advice. Please have in
mind that the inter retation of the writer of this newsletter about the news
published by the company does not represent the company official statement and
in fact may differ from the real meaning of what the news release meant to say.
Please read the news release by yourself and judge by yourself about the details
in it.



In compliance with Section 17(b), we disclose the holding of KWBT shares prior
to the publication of this report. Be aware of an inherent conflict of interest
resulting from such holdings

due to our intent to profit from the liquidation of these shares. Shares may be
sold at any time, even after positive statements have been made regarding the
above company.

Since we own shares, there is an inherent conflict of interest in our statements
and opinions. Readers of this publication are cautioned not to place undue
reliance on forward-looking statements,  which are based on certain
assumptions and expectations involving various risks and uncertainties, that
could cause results to differ materially from those set forth in the forward-
looking statements.



Please be advised that nothing within this email shall constitute a solicitation
or an offer to buy or sell any security mentioned herein. This newsletter is
neither a registered investment advisor nor affiliated with any broker or=20
dealer. All statements made are our express opinion only and should be treated
as such. We may own, buy and sell any securities mentioned at any time. This
report includes forward-looking statements within the meaning of The Private
Securities Litigation Reform Act of 1995. These statements may include terms as
"expect", "believe", "may", "will", "move", "undervalued" and "intend" or
similar terms.

This newsletter was paid $3,500 from third party to send this report. PLEASE DO
YOUR OWN DUE DILIGENCE BEFORE INVESTING IN ANY PROFILED COMPANY. You may lose
money from investing in Penny Stocks.